NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population

CompletedN/A

Sponsor: ANRS, Emerging Infectious Diseases

Conditions: Human Papillomavirus Infection, Human Immunodeficiency Virus Infection, Sexually Transmitted Diseases

Countries: France

The goal of this observational study is to estimate the prevalence of HPV infections anal and ENT level and according to HIV status in transgender (TG) population. The main question it aims to answer is: * What is the prevalence of HPV lesions in transgender population (TG); * What kind of high risk HPV (hrHPV) and low risk HPV (lrHPV) are detected at the genital, anal and ENT level

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria:

* Age ≥ 18 years
* To belong to transgender population : i.e. people who doesn't identify to the gender assigned at birth
* To be affiliated to a social security system or be beneficiary of AME

Exclusion criteria:

* To have ever been vaccinated against HPV
* Research participation refusal
* People under guardianship or curatorship, or deprived of liberty by administrative or judiciary measure

Locations (1)

Paris, France